Skip to content

Clinical trials

Phase 2 Squamous Cell Carcinoma of Head and Neck trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 2 Country / region: Canada Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20032
20051
20061
20101
20121
20131
20142
20151
20161
20183
20193
20202
20214
20221
20232
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting6
Terminated6
Recruiting3
Unknown status2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's4
Radiation Therapy Oncology Group4
National Cancer Institute (NCI)3
Merck Sharp & Dohme LLC2
University Health Network, Toronto2
ALX Oncology Inc.1
Alliance for Clinical Trials in Oncology1
AstraZeneca1
BeiGene1
Brooklyn ImmunoTherapeutics, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck34
Head and Neck Neoplasms17
Carcinoma, Non-Small-Cell Lung4
Carcinoma, Squamous Cell2
Salivary Gland Neoplasms2
Tongue Neoplasms2
Urinary Bladder Neoplasms2
Uterine Cervical Neoplasms2
Breast Neoplasms1
Carcinoma, Hepatocellular1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.